ADVERTISEMENT
Videos
Data From the EASE Trial Relative to Critical Limb Ischemia
10/13/2015
See a transcription of the full interview, "Data From the EASE Atherectomy Trial: An Interview With Tom Davis, MD."
At the 5th Annual Amputation Prevention Symposium, Vascular Disease Management spoke with Thomas Davis, MD, about the Endovascular Atherectomy Safety and Effectiveness (EASE) trial, an FDA-approved Investigational Device Exemption (IDE) clinical trial designed to evaluate the safety and effectiveness of the Phoenix Atherectomy catheter (Volcano Corporation), a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. Dr. Davis served as the national principal investigator for the trial.
